Physician profile
David S Jackson
NPI 1891796900
$25,686.66
in general payments reported to CMS, 2019-2025
22 companies · $14.55 in 2025
The $14.55 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $2,442 · 2021: $11K · 2022: $379 · 2023: $66.09 · 2024: $18.10 · 2025: $14.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $98.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $98.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $12,817.02 | 2020-2023 | Nexletol |
| Pfizer INC. | $8,222.20 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $2,909.27 | 2019-2021 | |
| Abbott Laboratories | $389.86 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $227.09 | 2019-2020 | |
| Akcea Therapeutics, INC. | $217.19 | 2019-2020 | |
| Amgen INC. | $212.78 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $160.90 | 2019-2025 | |
| Philips North America LLC | $112.32 | 2022-2023 | |
| Medtronic Vascular, INC. | $75.28 | 2019 | |
| Novo Nordisk INC | $61.15 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $45.91 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $37.16 | 2019-2020 | |
| Lilly USA, LLC | $36.33 | 2020 | |
| Arbor Pharmaceuticals, INC. | $30.96 | 2020-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $30.21 | 2020 | |
| Braemar Manufacturing, LLC | $19.23 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $18.10 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.49 | 2022 | |
| Sanofi-Aventis U.S. LLC | $16.97 | 2021 | |
| Radius Health, INC. | $15.94 | 2020 | |
| Quidel Corporation | $13.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.